Company Filing History:
Years Active: 2021
Title: Catherine Lancaster: Innovator in Immunogenic Compositions
Introduction
Catherine Lancaster is a notable inventor based in Southampton, PA (US). She has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions.
Latest Patents
Catherine holds 1 patent for her invention titled "Enhancing immunogenicity of polysaccharide-protein conjugates." This invention provides immunogenic compositions that include one or more polysaccharide-protein conjugates. These conjugates consist of polysaccharides derived from bacterial capsules that are conjugated to a carrier protein in an aprotic solvent, such as dimethylsulfoxide (DMSO). The invention also outlines methods for enhancing the immune response to a pneumococcal polysaccharide protein conjugate vaccine by administering an immunogenic composition prepared under DMSO conditions.
Career Highlights
Catherine is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research in immunogenic compositions. Her work has the potential to significantly impact vaccine development and public health.
Collaborations
Catherine has collaborated with esteemed colleagues, including Jian He and John E MacNair, to further her research and innovations in the field.
Conclusion
Catherine Lancaster's contributions to immunology through her innovative patent demonstrate her commitment to enhancing vaccine efficacy. Her work at Merck Sharp & Dohme Corporation continues to pave the way for advancements in immunogenic compositions.